Angel B. Jaramillo

Potent Antiretroviral Therapy of Primary Human Immunodeficiency Virus Type 1 (HIV‐1) Infection: Partial Normalization of T Lymphocyte Subsets and Limited Reduction of HIV‐1 DNA Despite Clearance of Plasma Viremia

John Zaunders, Philip Cunningham, Anthony D. Kelleher et al. · The Journal of Infectious Diseases · 1999 · 112 citations · Full text

Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects

Anthony D. Kelleher, MONIKA ROGGENSACK, Angel B. Jaramillo et al. · AIDS · 1998 · 54 citations

Development of a synthetic consensus sequence scrambled antigen HIV-1 vaccine designed for global use

Scott Thomson, Angel B. Jaramillo, Maryanne Shoobridge et al. · Vaccine · 2005 · 41 citations

Vaccination, Antigen Hiv-1 Vaccine, Vaccine Target +11

In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy

Tanya Applegate, Donald Birkett, Glen McIntyre et al. · Retrovirology · 2010 · 19 citations · Full text

Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success

Glen McIntyre, Yi Hsin Yu, Anna H. Tran et al. · Virology Journal · 2009 · 19 citations · Full text